Nebraska Community Blood Bank’s workforce and donor base includes diverse individuals of all races, ethnicities, genders, and sexual orientation. We value diversity in our community, donors, and team members, and we work to treat all with fairness, equality and respect.
On May 11, 2023, the U.S. Food and Drug Administration (FDA) issued final guidance establishing a blood donor screening process based on Individual Donor Assessment.
NCBB has strived to build an inclusive environment that embraces diversity for all who engage with our lifesaving mission. For decades, we have strongly advocated for scientifically-based changes to the FDA policies about men who have sex with men (MSM) and support the shift to individual donor assessment to determine eligibility. The FDA has finalized recommendations for establishing a blood donor screening process based on Individual Donor Assessment.
We recognize these changes are a monumental step forward, but we know there is still work to be done. We encourage the FDA’s continued evaluation of donor eligibility guidelines to make blood donation as inclusive and safe as possible.
To learn more about these changes, visit ncbb.org/ida.
